Bayer AGBayerBayer rebuilds pharma while waiting for Monsanto reliefA stronger pipeline and new financing give Bayer room to manoeuvre — but investors are still watching one issue: the US glyphosate litigation. more ➔
Wuxi AppTecChinaWuXi AppTec bets on expansion in EuropeGlobal science, local innovation: In an interview with European Biotech Magazine, WuXi AppTec Co-CEO Steve Yang explains why Europe remains a key source of scientific innovation, why the company continues … more ➔
TechnologyTargeted Protein Degradation: Designed to destroyTargeted protein degradation (TPD) has moved from a highly experimental concept to one of the most closely watched modalities in biopharma. What began with first-generation PROTACs (proteolysis-targeting … more ➔
Watchlist8 European VC firms to watch in 2026European biotech enters 2026 in a strange, almost contradictory mood. The easy-money years are gone, the post-pandemic correction has done its damage, and investors are no longer rewarding science … more ➔
M&ACan Sanofi buy its way into in vivo CAR-T?Recent preclinical data published in Molecular Therapy suggest the company may be closer than ever to answering that question. Its platform did not emerge from a single discovery programme, but from … more ➔
WhiteLab GenomicsInterviewAI: Breaking barriers in CNS researchDelivering therapeutic genetic material safely to the correct target in the body is one of the big challenges of modern medicine. We talked to David Del Bourgo, CEO of WhiteLab Genomics, about how AI … more ➔
Sevan Habeshian & Christian Heinis et al. https://www.nature.com/articles/s41467-022-31428-Drug DesignMacrocycles: big is the new beautifulIn the evolving landscape of drug discovery and new design, scientists and pharmaceutical innovators continually strive to develop therapies that are both highly selective and clinically effective, … more ➔
ServierVenture CapitalInside Servier’s new €200M venture fundWith the launch of Servier Ventures announced in January and a €200 million commitment to biotech investment, Servier is stepping up its engagement in early-stage innovation in oncology and neurology. … more ➔
CONCEPT HEIDELBERG GmbHPharmaCongressProfessor Wallhäußer Innovation Award 2026The 2026 Professor Wallhäußer Innovation Award was presented during this year’s PharmaCongress & PharmaTechnica 2026 at the end of March. First place went to AstraZeneca for the project “Automated … more ➔
Svitlana Hulko-freepik.comDeep DiveCan biotech finally fix infertility?According to the WHO, one adult in six globally is affected by infertility, but beyond this statistic, infertility is best understood as a couple’s problem, even when the underlying biology … more ➔
Bayer AG
Wuxi AppTec
WhiteLab Genomics
Sevan Habeshian & Christian Heinis et al. https://www.nature.com/articles/s41467-022-31428-
Servier
CONCEPT HEIDELBERG GmbH
Svitlana Hulko-freepik.com